Infectious Diseases · Clinical Calculator · Pharyngitis

Centor Score Strep Pharyngitis Probability

Score five clinical findings to estimate the probability of group A streptococcal (GAS) pharyngitis in a patient with a sore throat. Toggle between the classic Centor (four criteria, 0–4) and the McIsaac modification (adds an age adjustment, 0–5) to decide whom to test with a rapid antigen detection test or throat culture and whom to treat.

Published: References: 3 Read time:

← All calculators & tools  ·  CURB-65 for pneumonia →

Instructions
  1. Confirm the clinical setting: a patient presenting with an acute sore throat without features that make viral pharyngitis near-certain (cough, coryza, hoarseness, oral ulcers, conjunctivitis).
  2. Choose the scoring mode. McIsaac modified Centor (recommended) adds an age adjustment and is validated across children and adults; classic Centor omits age and is typically used in adults.
  3. Tick each clinical criterion present. The running total updates automatically.
  4. Read the risk band for the probability of a positive throat culture or rapid antigen detection test (RADT) and the suggested next step for testing and antibiotic use, per the Infectious Diseases Society of America (IDSA) 2012 guideline.

All computation runs in your browser; no values are stored or transmitted.

When to Use

Use the Centor or McIsaac-modified Centor score in a patient who presents with an acute sore throat and in whom you are deciding whether to swab for group A Streptococcus and whether to prescribe antibiotics. It is designed to help you concentrate testing on patients with a reasonable pre-test probability of GAS pharyngitis and to avoid empirical antibiotics in those unlikely to benefit.

✅

Appropriate population

Adults and children aged 3 years and older presenting with acute pharyngitis. The McIsaac modification is validated across the full age range (3 years to older adults). Below age 3 the pre-test probability of GAS is low and acute rheumatic fever is uncommon — individualized testing is preferred and the score is not routinely used.

⚠️

When NOT to rely on it

The score does not apply to chronic or recurrent sore throat, peritonsillar abscess, suspected deep-neck infection, immunocompromised patients, or epidemiologic settings with elevated pre-test probability (close contact of a confirmed GAS case, known outbreak). Features of a viral syndrome (cough, coryza, rhinorrhea, hoarseness, conjunctivitis, oral ulcers) argue against GAS regardless of the Centor total.

Pearls & Pitfalls
💡

Even a high score is not a diagnosis

The IDSA 2012 guideline advises against empirical antibiotic treatment of adults with a high Centor score in the absence of a positive microbiologic test. Clinical criteria alone cannot distinguish GAS from viral pharyngitis reliably enough to justify treatment; confirm with a rapid antigen detection test (RADT) and, in children and adolescents, a confirmatory throat culture if the RADT is negative. In adults, a negative RADT does not require routine backup culture because the baseline risk of acute rheumatic fever is very low.

🔬

McIsaac vs. classic Centor

Classic Centor was derived in adults in an emergency department (Centor 1981). McIsaac extended and prospectively validated the rule across community primary-care patients 3 years and older by adding an age modifier (+1 for 3–14 years, 0 for 15–44 years, −1 for 45 years and older). The McIsaac form is now the more widely cited bedside rule and is preferred when a single score must cover children and adults.

🚫

Pitfalls

(1) GAS carriage: up to 10–20% of school-aged children carry GAS asymptomatically; a positive RADT in a child with a viral syndrome may represent carriage, not active infection. (2) Scarlet fever, strawberry tongue, palatal petechiae and a sand-paper rash raise the pre-test probability beyond the score — document them and test. (3) Do not use the Centor score to rule out alternative serious diagnoses — epiglottitis, retropharyngeal or peritonsillar abscess, Lemierre's syndrome, and infectious mononucleosis all deserve separate consideration when the examination or course does not fit a simple pharyngitis.

Why Use It

Most sore throats in adults are viral, and empirical antibiotics for pharyngitis drive avoidable antibiotic use, cost, adverse events, and resistance. A structured clinical rule stratifies patients by the probability that their sore throat is GAS, so that low-probability patients are not swabbed or treated, intermediate-probability patients are tested with a RADT or throat culture, and high-probability patients are still confirmed microbiologically before treatment under current IDSA guidance. Scoring also enforces documentation of the exam findings that matter (exudate, lymphadenopathy, fever, absence of cough) and helps clinicians and patients discuss why "waiting on the swab" or "no antibiotics today" is the right answer when it is.

Centor Score (Modified/McIsaac) — Strep Pharyngitis Probability

Tick each criterion the patient has. The McIsaac modification adds an age-based modifier and is validated in children and adults; classic Centor omits age (typically used in adults).

e.g. 15–44 years. Used only in McIsaac mode; ignored in classic Centor.
0
Total Score
McIsaac (0–5)
—
Est. GAS Probability
per culture data
—
Risk Band
enter findings

⚕ Centor RM et al. Med Decis Making. 1981;1(3):239–246. McIsaac WJ et al. JAMA. 2004;291(13):1587–1595. Shulman ST et al. Clin Infect Dis. 2012;55(10):e86–e102 (IDSA guideline). This rule stratifies the pre-test probability of group A streptococcal pharyngitis; it does not confirm or exclude GAS. IDSA 2012 recommends against empirical antibiotic treatment of adults with high Centor scores in the absence of a positive microbiologic test. For licensed clinicians; not a substitute for individualized assessment.

Next Steps

Use the score band to decide on rapid antigen detection testing, throat culture, and antibiotics.

  • Score ≤ 1: group A streptococcus unlikely (about 1–10%). Neither testing nor antibiotics are routinely indicated. Explain the viral nature of most sore throats, offer symptom relief (analgesia, hydration, saltwater gargles), and define return precautions.
  • Score 2–3: intermediate probability (about 11–35%). Perform a rapid antigen detection test (RADT); if positive, treat with a narrow-spectrum agent (penicillin V or amoxicillin as first line; a macrolide or first-generation cephalosporin for the penicillin-allergic). In children and adolescents, back up a negative RADT with a throat culture; in adults this is not routinely required.
  • Score ≥ 4: higher probability (about 51–53%). Still confirm with a rapid antigen detection test or throat culture before prescribing antibiotics, per IDSA 2012. Avoid routine empirical treatment in adults, even with a high Centor score. Treat only on a positive result unless local protocols direct otherwise.
  • Always pair the score with inspection for complications — peritonsillar abscess, airway compromise, a classic scarlet fever rash, or features suggesting infectious mononucleosis — and reassess if the course is atypical.
Evidence & References

Scoring criteria

CriterionPoints
Tonsillar exudates or swelling+1
Tender or swollen anterior cervical lymph nodes+1
Fever history > 38 °C / 100.4 °F+1
Absence of cough+1
Age 3–14 years (McIsaac only)+1
Age 15–44 years (McIsaac only)0
Age ≥ 45 years (McIsaac only)−1

Probability of positive culture / GAS by band (IDSA 2012)

ScoreEst. probability of GASSuggested action
≤ 01–2.5%No testing, no antibiotics
15–10%No testing, no antibiotics
211–17%Rapid antigen detection test or throat culture; treat if positive
328–35%Rapid antigen detection test or throat culture; treat if positive
≥ 451–53%Rapid antigen detection test or culture; IDSA 2012 still recommends confirmation before antibiotics

The Centor criteria were derived in an adult emergency-department cohort (Centor 1981). McIsaac and colleagues (2004) prospectively validated an age-modified score in community primary-care practice spanning children and adults. IDSA 2012 (Shulman) harmonized management: confirm with a microbiologic test before antibiotics, even at high clinical scores in adults, to curb unnecessary antibiotic use.

References

  1. Centor RM, Witherspoon JM, Dalton HP, Brody CE, Link K. The diagnosis of strep throat in adults in the emergency room. Med Decis Making. 1981;1(3):239–246. doi:10.1177/0272989X8100100304.
  2. McIsaac WJ, Kellner JD, Aufricht P, Vanjaka A, Low DE. Empirical validation of guidelines for the management of pharyngitis in children and adults. JAMA. 2004;291(13):1587–1595. doi:10.1001/jama.291.13.1587.
  3. Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G, Martin JM, Van Beneden C. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis. 2012;55(10):e86–e102. doi:10.1093/cid/cis629.
Important: This calculator is an educational aid for licensed clinicians and does not replace individualized clinical assessment. The Centor and McIsaac scores stratify the pre-test probability of group A streptococcal pharyngitis; they do not confirm or exclude GAS, and they do not replace rapid antigen detection testing, throat culture, or sound clinical judgment. In adults, IDSA 2012 recommends against empirical antibiotics on the basis of clinical criteria alone, even at high scores. Always rule out serious mimics (peritonsillar abscess, epiglottitis, retropharyngeal abscess, Lemierre's syndrome, mononucleosis) when the examination or course is atypical, and follow local antimicrobial stewardship policies.
References 3 sources
  1. Centor, R. M., Witherspoon, J. M., Dalton, H. P., Brody, C. E., & Link, K. (1981). The diagnosis of strep throat in adults in the emergency room. Medical Decision Making, 1(3), 239–246. https://doi.org/10.1177/0272989X8100100304
  2. McIsaac, W. J., Kellner, J. D., Aufricht, P., Vanjaka, A., & Low, D. E. (2004). Empirical validation of guidelines for the management of pharyngitis in children and adults. JAMA, 291(13), 1587–1595. https://doi.org/10.1001/jama.291.13.1587
  3. Shulman, S. T., Bisno, A. L., Clegg, H. W., Gerber, M. A., Kaplan, E. L., Lee, G., Martin, J. M., & Van Beneden, C. (2012). Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clinical Infectious Diseases, 55(10), e86–e102. https://doi.org/10.1093/cid/cis629
Dr. W Rivero, MD

W Rivero, MD, FPCP, DPSN

Specialist in Internal Medicine, Nephrology, and Clinical Nutrition. Practicing integrative and evidence-based nephrology across Quezon City, Pampanga, and Bulacan.

· Book an Appointment →

QR code — scan to save Dr. Rivero's contact info

Scan and save

All Calculators Related Guides